How to Help Your Patients Save Money on Clobex: A Provider's Guide to Savings Programs

For dermatologists, PCPs, and other prescribers, medication cost is a real barrier to patient adherence — and Clobex (clobetasol propionate) is no exception. Brand-name Clobex spray can exceed $460 without insurance, and most Medicare Part D and private insurance plans do not cover it. This guide gives you the tools to help your patients access this medication affordably.

Understanding the Cost Landscape for Clobex

Clobex pricing varies significantly by formulation and coverage status:

Brand Clobex spray (59 mL): ~$461 cash price without insurance

Generic clobetasol propionate cream (60 g): ~$226 average retail; as low as $23 with GoodRx

Insurance coverage: Not covered by most Medicare Part D plans or commercial plans for brand name; generic has better but inconsistent coverage

The cost gap between brand and generic is enormous — and generic clobetasol propionate is bioequivalent. For most patients, writing for generic is the single most effective cost-reduction move a prescriber can make.

Step 1: Default to Generic Unless Clinically Contraindicated

Write "clobetasol propionate 0.05%" rather than "Clobex" unless there is a specific clinical reason the brand is required. Generic formulations are FDA-approved bioequivalents. For most patients, there is no clinical difference between brand and generic — but there can be a $200-400 difference in cost per fill.

Step 2: Counsel Patients on GoodRx and Discount Programs

GoodRx and SingleCare are free prescription discount programs that significantly reduce the cost of generic clobetasol at most retail pharmacies. With GoodRx, patients can pay as little as $9-23 depending on formulation and pharmacy. Adding this information to your after-visit summary or patient handout can prevent abandonment at the pharmacy counter.

Key point for staff: GoodRx pricing varies by pharmacy. Encourage patients to compare prices on the GoodRx website before choosing where to fill their prescription — the price difference can be substantial between pharmacies in the same neighborhood.

Step 3: PAN Foundation Patient Assistance Program

The PAN Foundation offers financial assistance for clobetasol-eligible patients who have insurance and a valid prescription. This program is particularly useful for patients who are underinsured or who face high out-of-pocket costs under their plan.

PAN Foundation: 1-866-316-7263 | panfoundation.org

Requirements: Must have insurance and a valid prescription

Your MA or front desk staff can provide this information to patients at checkout as part of a standard shortage/cost handout.

Step 4: Galderma Manufacturer Savings Cards

Galderma Laboratories, the manufacturer of brand-name Clobex, may offer savings programs or copay assistance cards for commercially insured patients. These typically reduce or eliminate copays for brand-name prescriptions. Check the Galderma website or contact their medical affairs team for current program details. Note: manufacturer programs typically do not apply to patients on Medicare, Medicaid, or other government-funded insurance.

Step 5: Prior Authorization and Formulary Exception Strategies

If a patient's insurance does not cover clobetasol, prior authorization (PA) or a formulary exception may be appropriate in cases of medical necessity:

Prior authorization: Required for about 1 in 5 patients on ACA plans for clobetasol topical solution. Indicate the severity of the diagnosis, failure of lower-potency agents, and clinical necessity.

Formulary exception: If clobetasol is not on the plan's formulary, submit a formulary exception citing medical necessity, failed alternatives, and patient safety needs.

Step therapy appeals: If the plan requires trying lower-potency steroids first (step therapy), document that appropriate lower-potency agents were tried and proved insufficient. This documentation strengthens a PA or exception request.

Step 6: Consider Alternative Therapeutically Equivalent Agents with Better Coverage

For patients where cost is the primary barrier, consider whether a therapeutically equivalent alternative with better formulary placement exists:

Halobetasol propionate: Another Class I super-potent steroid. Generic is available and may have better insurance formulary placement.

Calcipotriene/betamethasone combination (Taclonex): For scalp psoriasis, this combination product may offer better formulary coverage at some plans.

Creating a Cost Conversation Protocol for Your Practice

Systematizing how your practice addresses medication cost barriers can prevent poor outcomes from pharmacy abandonment:

At the point of prescribing: Check the patient's formulary and ask about insurance coverage before deciding brand vs. generic

At checkout: Provide a savings card or printed GoodRx information for generic clobetasol

Follow-up: At 2-week check-in, confirm patient was able to fill the prescription — cost barriers often go unreported

Also Dealing With Availability Issues?

If your patients are struggling to find Clobex in stock in addition to cost barriers, visit medfinder for Providers and review our guide on helping your patients find Clobex in stock.